These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. In vitro activities of colistin and ampicillin/sulbactam against Acinetobacter baumannii. Punpanich W, Munsrichoom A, Srisarang S, Treeratweeraphong V. J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S95-100. PubMed ID: 22043760 [Abstract] [Full Text] [Related]
29. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. Cai Y, Chai D, Wang R, Liang B, Bai N. J Antimicrob Chemother; 2012 Jul; 67(7):1607-15. PubMed ID: 22441575 [Abstract] [Full Text] [Related]
32. In-vitro bactericidal activity of colistin against biofilm-associated Pseudomonas aeruginosa and Acinetobacter baumannii. Cai Y, Wang R, Liang BB, An MM. J Hosp Infect; 2009 Aug; 72(4):368-70. PubMed ID: 19443079 [No Abstract] [Full Text] [Related]
38. Therapeutic options for Acinetobacter baumannii infections. Vila J, Pachón J. Expert Opin Pharmacother; 2008 Mar; 9(4):587-99. PubMed ID: 18312160 [Abstract] [Full Text] [Related]
39. Emergence of rifampicin, tigecycline, and colistin-resistant Acinetobacter baumannii in Iran; spreading of MDR strains of novel International Clone variants. Bahador A, Taheri M, Pourakbari B, Hashemizadeh Z, Rostami H, Mansoori N, Raoofian R. Microb Drug Resist; 2013 Oct; 19(5):397-406. PubMed ID: 23768166 [Abstract] [Full Text] [Related]
40. Colistin, meropenem and rifampin in a combination therapy for multi-drug-resistant Acinetobacter baumannii multifocal infection. A case report. Biancofiore G, Tascini C, Bisà M, Gemignani G, Bindi ML, Leonildi A, Giannotti G, Menichetti F. Minerva Anestesiol; 2007 Mar; 73(3):181-5. PubMed ID: 17159765 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]